| Prev Close | 15.37 |
| Day Low/High | 15.33 / 16.03 |
| 52 Wk Low/High | 5.61 / 25.10 |
| Avg Volume | 7.93M |
Cronos Group Inc. (CRON)
15.38
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 334.09M |
| Market Cap | 5.12B |
| EPS | -0.10 |
| P/E Ratio | 40.45 |
| Div & Yield | N.A. (N.A) |
Latest News
Altria or Philip Morris International: Which Is the Better Dividend Stock?
While the two tobacco giants have similar yields, both also have very different businesses, with different growth potential in the years ahead.
Use Caution on Small-Caps, Plus Apple, Tesla and McDonald's: Market Recon
Equity markets marked time on Monday, mostly on light volume.
Cronos Group Certainly Qualifies for Mainstream Consideration
Revenue is where it's at for cannabis in 2019.
2 Big Earnings Reports I'll Be Watching This Week
A huge week is coming up for these well-known stocks.
7 Indirect Stock Plays on the Cannabis Sector
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
Tilray Stock Lights Up as Partnerships Obscure Profitability Problem
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.
Chart of the Day: Vetting the Value of Cannabis Companies
Assessing Aurora and its peers, strictly on the numbers.
Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot
In this day and age, companies must be 'disruptors' or get left in the dust.
Peltz Is the Perfect Problem Solver for Aurora Cannabis
Peltz's addition should pacify a persistent critique of the company.
Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
Melius Research Launches Cannabis Industry Coverage
In its first report on cannabis companies, Melius says prices are high.
Can Cronos Group Soar Higher? Looks Like it
The stock price of the cannabis company has been on a roll and is poised to move even higher still.
Jim Cramer: My Best Stock Picks for Cannabis and China
And why I won't recommend any other stocks in these markets, right now.
Short-Selling Is Really Hard. Just Ask Citron Research
Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.
Pot Stocks Fade as Momentum Cools
There are some big shifts Wednesday in names that have recently been the hottest.
Is Apple Aggressively Buying Back Its Stock?
Without Apple doing so well Monday the indices would look much different.
How Are My Ideas Working Out? January Trade Review (Part 1)
Eight of these 11 trade ideas are in the green, with a few big winners.
Cannabis Stocks Are Getting Their Second Wind
Let's check out the charts of four big names in the space.
Chart of the Day, Part 2: A Closer Look at Constellation's Big Cannabis Bet
Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.
Real Money Goes Behind the Scenes of the Budding Cannabis Industry
In the interest of due diligence, we went and took a close look at the ground floor of the newest investment craze.
How to Trade Cronos, the Cannabis Firm With Ties to Big Tobacco
What matters here is the ability to innovate, market, and sell.
Who Hasn't Crashed the Cannabis Party Yet?
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
Tilray Is Now a Top-Tier Cannabis Play
I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.
